Opening Harnessing Hypoxia Biology for Cancer Therapy (Yale Cancer Center Grand Rounds)
Harnessing Hypoxia Biology for Cancer Therapy (Yale Cancer Center Grand Rounds)
- Length
- 51 min
- Level
- Research
- Recorded
- Yale University2024
Chapter 1 of 8: Before the lecture
Glazer shows cediranib mimics hypoxic DNA repair suppression, sensitizing tumors to PARP and WEE1 inhibitors.
Tumor hypoxia drives genetic instability by suppressing DNA repair, and Glazer turns that mechanism into a drug strategy at Yale Cancer Center Grand Rounds. He starts with how low oxygen downregulates homologous recombination and mismatch repair through retinoblastoma protein phosphorylation and E2F complexes. Stress-induced mutagenesis in E. coli serves as an evolutionary parallel. The anti-angiogenic drug cediranib phenocopies this suppression, creating synthetic lethality with PARP inhibitors such as olaparib. Paired with a WEE1 inhibitor in uterine serous cancer, cediranib lowers MLH1, activates LINE-1 retroelements and triggers cGAS-STING signaling, with xenograft data showing tumor growth suppression.
Tumor hypoxia drives genetic instability by suppressing DNA repair, and Glazer turns that mechanism into a drug strategy at Yale Cancer Center Grand Rounds. He starts with how low oxygen downregulates homologous recombination and mismatch repair through retinoblastoma protein phosphorylation and E2F complexes. Stress-induced mutagenesis in E. coli serves as an evolutionary parallel. The anti-angiogenic drug cediranib phenocopies this suppression, creating synthetic lethality with PARP inhibitors such as olaparib. Paired with a WEE1 inhibitor in uterine serous cancer, cediranib lowers MLH1, activates LINE-1 retroelements and triggers cGAS-STING signaling, with xenograft data showing tumor growth suppression.
Hallmarks of Cancer
Mutator Phenotype May Be Required for Multistage Carcinogenesis
Hypoxia-Induced Epigenetic Regulation and Silencing of the BRCA1 Promoter
DNA Repair 32 (2015) 180-189
JCO clinical trial paper on metastatic prostate cancer
NEJM article on Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

This lecture
Talk 9 of 26 of Yale Cancer Center Grand Rounds.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above.
Press a chosen node again to open it.
Your comment is kept while you sign up.Sign in
Alana's paper